Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
Recruiting
Observational Study
RSV Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Day – 24 Months
- Sex
- Any
- Study type
- Observational
- Participants needed
- 42,000 (estimated)
- Sponsor
- Federico Martinón Torres · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A longitudinal observational study based on routinely collected data on hospital and health care use for RSV infections will be undertaken. The Galician public health registries will be used for data collection including baseline information and follow-up data. Historical data will be retrieved for comparison purposes. The study aims to observe and analyze data from all the eligible children in Ga…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects born in Galicia from April 1st, 2023 and March 1st, 2026
Exclusion Criteria:
* No specific criteria has been reported
Contacts
No contact information available.